Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study

Diabetic Medicine

Volumn 21, Issue 4, 2004, Pages 324-328

  Hummel, M ^a,c   Ziegler, A G ^a   Roth, R ^b  

^a Klinikum Schwabing   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

Antibody screening; Prospective design; Psychology; Type 1 diabetes

Indexed keywords

AUTOANTIBODY;

ANTIBODY DETECTION; ANXIETY; ARTICLE; BIRTH; BLOOD EXAMINATION; CHILD; COUNSELING; DIAGNOSTIC ACCURACY; FAMILY; FEMALE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PANCREAS ISLET; PROGENY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RATING SCALE; RISK ASSESSMENT; RISK FACTOR;

ANXIETY; ATTITUDE TO HEALTH; AUTOANTIBODIES; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FATHERS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ISLETS OF LANGERHANS; MALE; MOTHERS; PARENTS; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; SEROLOGIC TESTS;

EID: 1942487718     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01142.x     Document Type: Article

References (26)

1. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for the development of childhood diabetes in offspring of parents with type 1 diabetes: the German BABY-DIAB Study. Diabetes 1999; 48: 460-468.
2. Norris JM, Beaty B, Klingensmith G, Yu L, Hoffman M, Chase HP et al. Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young. JAMA 1996; 276: 609-614.
3. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000; 97: 1701-1706.
4. Couper JJ, Steele C, Beresford S, Powell T, McCaul K, Pollard A et al. Lack of association between duration of breast feeding or introduction of cow's milk and development of islet autoimmunity. Diabetes 1999; 48: 2145-2149.
5. Weber B, Roth R. Psychological aspects in diabetes prevention trials. Ann Med 1997; 29: 461-467.
6. Roth R. Psychological and ethical aspects of prevention trials. J Ped Endocr Metab 2001; 14: 669-674.
7. Johnson SB, Riley WJ, Hansen CA, Nurick MA. Psychological impact of islet cell-antibody screening. Diabetes Care 1990; 13: 93-97.
8. Johnson SB, Tercyak KP. Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care 1995; 18: 1370-1372.
9. Carmichael SK, Johnson SB, Weiss A, Fuller KG, She JX, Schatz DA. Psychological impact of screening programs in mothers of children at-risk for type 1 diabetes. Diabetes 2000; 49: A317.
10. Johnson SB. Psychological impact of screening programs for DM. J Ped Endocr Metab 2001; 14: 653-659.
11. Shaw C, Abrams K, Marteau TM. Psychological impact of predicting individuals' risk of illness: a systematic review. Soc Sci Med 1999; 49: 1571-1598.
12. Marteau TM. Towards an understanding of the psychological consequences of screening. In Croyle RT ed. Psychosocial Effects of Screening for Disease Prevention and Detection. New York: Oxford University Press, 1995: 185-199.
13. Yu MS, Norris JM, Mitchell CM, Butler-Simon N, Groshek M, Follansbee D et al. Impact of maternal parenting stress of receipt of genetic information regarding risk of diabetes in newborn infants. Am J Med Genet 1999; 86: 219-226.
14. Wagnet A, Tibben A, Bruining GJ, Aanstoot HJ, Blondeau M, Niermeijer MF. Preliminary experience with predictive testing for insulin-dependent diabetes mellitus. Lancet 1995; 346: 380-381.
15. Ludvigsson J, Ludvigsson M, Sepa A. Screening for prediabetes in the general child population: maternal attitude to participation. Ped Diab 2001; 2: 170-174.
16. Carmichael SK, Johnson SB, Fuller KG, Taylor KR, She JX, Schatz DA. Newborn genetic screening for type 1 diabetes: psychological impact and factors predicting continued study participation. Diabetes 1999; 48 (Suppl. 1): A322.
17. Carmichael SK, Johnson SB, Fuller KG, Taylor KR, She JX, Schatz DA. Newborn genetic screening for type 1 diabetes maternal understanding of infant risk. Diabetes 1999; 48 (SuppL 1): A323.
18. Laux L, Glanzmann P, Schaffner P, Spielberger CD. Das State-Trait-Angstinventar. Weiheim: Beltz, 1970 (German version of Spielberger CD, Gorsuch RL, Lushene R). Test Manual of the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists, 1970.
19. Laux L, Glanzmann P, Schaffner P, Spielberger CD. Das State-Trait-Angstinventar. Weiheim: Beltz, 1970 (German version of Spielberger CD, Gorsuch RL, Lushene R). Test Manual of the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists, 1970.
20. Ross LF. Minimizing risks. The ethics of predictive diabetes mellitus screening research in newborns. Arch Pediatr Adolesc Med 2003; 157: 89-95.
21. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-1310.
22. Hummel M, Bonifacio E, Naserke H, Schenker M, Ziegler AG. Characteristics of humoral islet autoimmunity differ according to the age of islet autoantibody appearance. Diabetes 2001; 50 (Suppl. 2): A85.
23. Gardner SG, Gale EA, Williams AJ, Gillespie KM, Lawrence KE, Bottazzo GF et al. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care 1999; 22: 2049-2054.
24. Galatzer A, Green E, Ofan R, Benzaquen H, Yosefsberg Z, Weintrob N et al. Psychological impact of islet cell antibody screening. J Pediatr Endocr Metabol 2001; 14 (Suppl. 1): 675-679.
25. Hendrieckx C, De Smet F, Kristoffersen I, Bradley C. Risk assessment for developing type 1 diabetes: intentions of behavioural changes prior to risk notification. Diabetes Matabol Res Rev 2002; 18: 36-42.
26. Naserke HE, Bonifacio E, Ziegler AG. Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab 1999; 84: 1239-1243.